These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37853868)

  • 1. A Systemic Lupus Erythematosus Patient with Cutaneous
    Kim J; Hasegawa T; Tada K; Uehara Y; Fukui Y; Nakamura A; Takei S; Mitarai S; Aono A; Ikeda S
    Ann Dermatol; 2023 May; 35(Suppl 1):S63-S66. PubMed ID: 37853868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacteriological features of Mycobacterium haemophilum isolated from skin lesions in an immunodeficient patient].
    Saito H; Toda K; Matsumoto I; Matsuo K; Nakanaga K; Ishii N
    Kansenshogaku Zasshi; 2004 May; 78(5):389-97. PubMed ID: 15211860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Belimumab in Systemic Lupus Erythematosus.
    Srivastava A
    Indian J Dermatol; 2016; 61(5):550-3. PubMed ID: 27688447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator.
    Drugs R D; 2008; 9(3):197-202. PubMed ID: 18457473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of bullous lupus with corticosteroids and belimumab: A case report.
    Keshavamurthy C; Fibeger E; Virata A; Bansal P
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):52-56. PubMed ID: 35538618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report.
    Danve A; Perry L; Deodhar A
    Semin Arthritis Rheum; 2014 Oct; 44(2):195-7. PubMed ID: 25005336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus.
    Furie R; Stohl W; Ginzler EM; Becker M; Mishra N; Chatham W; Merrill JT; Weinstein A; McCune WJ; Zhong J; Cai W; Freimuth W;
    Arthritis Res Ther; 2008; 10(5):R109. PubMed ID: 18786258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
    Furie R; Petri M; Zamani O; Cervera R; Wallace DJ; Tegzová D; Sanchez-Guerrero J; Schwarting A; Merrill JT; Chatham WW; Stohl W; Ginzler EM; Hough DR; Zhong ZJ; Freimuth W; van Vollenhoven RF;
    Arthritis Rheum; 2011 Dec; 63(12):3918-30. PubMed ID: 22127708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular Mycobacterium haemophilum infection originating in the cornea: a case report.
    Zhang YQ; Xu TT; Wang FY; Wang S; Cheng J
    BMC Infect Dis; 2023 Mar; 23(1):140. PubMed ID: 36882753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case of Mycobacterium haemophilum misdiagnosed as Mycobacterium intracellulare due to one base insertion in the bacterial genome.
    Nishikawa R; Yamada Y; Kanki H; Matsuoka H; Nakamura T; Jikimoto T; Kusuki M; Ishii N; Ohnuma K; Nakanaga K; Nishigori C
    J Dermatol; 2018 Jan; 45(1):64-66. PubMed ID: 28771786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Lupus Erythematosus-Associated Serositis Managed With Intravenous Belimumab: A Case Report.
    Mukkera S; Mannem M; Chamarti K; Pillarisetty L; Vulasala SS; Alahari L; Ammu A; Mukkera A; Vadlapatla RK
    Cureus; 2022 Feb; 14(2):e22639. PubMed ID: 35242484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Belimumab for the treatment of recalcitrant cutaneous lupus.
    Vashisht P; Borghoff K; O'Dell JR; Hearth-Holmes M
    Lupus; 2017 Jul; 26(8):857-864. PubMed ID: 28121495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium kansasii infection presenting as cellulitis in a patient with systemic lupus erythematosus.
    Hsu PY; Yang YH; Hsiao CH; Lee PI; Chiang BL
    J Formos Med Assoc; 2002 Aug; 101(8):581-4. PubMed ID: 12440090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil.
    Teh CL; Kong KO; Chong AP; Badsha H
    Lupus; 2002; 11(4):249-52. PubMed ID: 12043889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First case presentation of refractory pediatric bullous lupus erythematosus (BSLE) treatment with belimumab.
    Zeng HQ; Lu XP; Yan ZB; Ye ZZ
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7980-7985. PubMed ID: 36394748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab.
    Fredericks CA; Kvam KA; Bear J; Crabtree GS; Josephson SA
    Lupus; 2014 Jun; 23(7):711-3. PubMed ID: 24531080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
    Navarra SV; Guzmán RM; Gallacher AE; Hall S; Levy RA; Jimenez RE; Li EK; Thomas M; Kim HY; León MG; Tanasescu C; Nasonov E; Lan JL; Pineda L; Zhong ZJ; Freimuth W; Petri MA;
    Lancet; 2011 Feb; 377(9767):721-31. PubMed ID: 21296403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
    Teng YKO; Bruce IN; Diamond B; Furie RA; van Vollenhoven RF; Gordon D; Groark J; Henderson RB; Oldham M; Tak PP
    BMJ Open; 2019 Mar; 9(3):e025687. PubMed ID: 30898822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Belimumab: a step forward in the treatment of systemic lupus erythematosus.
    Depascale R; Gatto M; Zen M; Saccon F; Larosa M; Zanatta E; Bindoli S; Doria A; Iaccarino L
    Expert Opin Biol Ther; 2021 May; 21(5):563-573. PubMed ID: 33630721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.